Association of ESR1 gene tagging SNPs with breast cancer risk
- PMID: 19126777
- PMCID: PMC2722230
- DOI: 10.1093/hmg/ddn429
Association of ESR1 gene tagging SNPs with breast cancer risk
Abstract
We have conducted a three-stage, comprehensive single nucleotide polymorphism (SNP)-tagging association study of ESR1 gene variants (SNPs) in more than 55,000 breast cancer cases and controls from studies within the Breast Cancer Association Consortium (BCAC). No large risks or highly significant associations were revealed. SNP rs3020314, tagging a region of ESR1 intron 4, is associated with an increase in breast cancer susceptibility with a dominant mode of action in European populations. Carriers of the c-allele have an odds ratio (OR) of 1.05 [95% Confidence Intervals (CI) 1.02-1.09] relative to t-allele homozygotes, P = 0.004. There is significant heterogeneity between studies, P = 0.002. The increased risk appears largely confined to oestrogen receptor-positive tumour risk. The region tagged by SNP rs3020314 contains sequence that is more highly conserved across mammalian species than the rest of intron 4, and it may subtly alter the ratio of two mRNA splice forms.
Figures
References
-
- Hill S.M., Fuqua S.A., Chamness G.C., Greene G.L., McGuire W.L. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res. 1989;49:145–148. - PubMed
-
- Weel A.E., Uitterlinden A.G., Westendorp I.C., Burger H., Schuit S.C., Hofman A., Helmerhorst T.J., van Leeuwen J.P., Pols H.A. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J. Clin. Endocrinol. Metab. 1999;84:3146–3150. - PubMed
-
- Okura T., Koda M., Ando F., Niino N., Ohta S., Shimokata H. Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int. J. Obes. Relat. Metab. Disord. 2003;27:1020–1027. - PubMed
-
- Schuit S.C., Oei H.H., Witteman J.C., Geurts van Kessel C.H., van Meurs J.B., Nijhuis R.L., van Leeuwen J.P., de Jong F.H., Zillikens M.C., Hofman A., et al. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. J. Am. Med. Assoc. 2004;291:2969–2977. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 CA069417/CA/NCI NIH HHS/United States
- CA065725/CA/NCI NIH HHS/United States
- U01 CA69417/CA/NCI NIH HHS/United States
- R01-CA121245-01A2/CA/NCI NIH HHS/United States
- U01-CA98233/CA/NCI NIH HHS/United States
- 19275/CRUK_/Cancer Research UK/United Kingdom
- C1287/A7497/CRUK_/Cancer Research UK/United Kingdom
- C20/A3084/CRUK_/Cancer Research UK/United Kingdom
- 10118/CRUK_/Cancer Research UK/United Kingdom
- U01 CA69467/CA/NCI NIH HHS/United States
- 10124/CRUK_/Cancer Research UK/United Kingdom
- U01 CA069638/CA/NCI NIH HHS/United States
- C490/A11021/CRUK_/Cancer Research UK/United Kingdom
- R01 CA121245/CA/NCI NIH HHS/United States
- U01 CA069467/CA/NCI NIH HHS/United States
- 11022/CRUK_/Cancer Research UK/United Kingdom
- CA122340/CA/NCI NIH HHS/United States
- R01 CA104021/CA/NCI NIH HHS/United States
- R01 CA065725/CA/NCI NIH HHS/United States
- P50 CA116201/CA/NCI NIH HHS/United States
- 11021/CRUK_/Cancer Research UK/United Kingdom
- CA098233/CA/NCI NIH HHS/United States
- U01 CA098233/CA/NCI NIH HHS/United States
- U01 CA69638/CA/NCI NIH HHS/United States
- R01 CA 104021/CA/NCI NIH HHS/United States
- R01 CA122340/CA/NCI NIH HHS/United States
